Related Experiment Video
Updated: Aug 4, 2026

08:51
Evaluation of Polymeric Gene Delivery Nanoparticles by Nanoparticle Tracking Analysis and High-throughput Flow Cytometry
Published on: March 1, 2013
16.0K
Excipient-Free Ionizable Polyester Nanoparticles for Lung-Selective and Innate Immune Cell Plasmid DNA and mRNA
Atanu Chakraborty1, Shruti Dharmaraj1, Nhu Truong1
1Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, 20 N. Pine Street, Baltimore, Maryland21201, United States.
ACS Applied Materials & Interfaces
|December 16, 2022
Summary
This study introduces a novel, single-component polymer nanoparticle for nucleic acid delivery, achieving lung-selective transfection in vivo. The excipient-free platform effectively targets innate immune cells without causing harm, simplifying genetic medicine development.
Area of Science:
- Polymer chemistry
- Nanotechnology
- Gene delivery
Background:
- Current polymer-based nucleic acid delivery systems often require complex synthesis, purification, and excipients for efficacy.
- Achieving targeted delivery, particularly to the lungs and innate immune cells, remains a challenge.
- Enhancing stability, endosomal escape, and in vivo performance are critical for clinical translation.
Purpose of the Study:
- To develop a simplified, excipient-free, single-component polymer nanoparticle platform for nucleic acid delivery.
- To achieve lung-selective gene transfection in vivo.
- To enable targeted delivery to hard-to-transfect innate immune cells.
Main Methods:
- Synthesis of a polyester-based nanoparticle platform using ionizable N-methyldiethanolamine (MDET) and hydrophobic alkyl diols (Cp).
- Formulation of polyplexes with plasmid DNA (pDNA) or messenger RNA (mRNA).
- In vivo evaluation of nanoparticle stability, serum resistance, and transfection efficiency in lung cells (alveolar macrophages, dendritic cells).
Main Results:
- The single-component, excipient-free platform demonstrated high serum and enzymatic stability.
- Polymer nanoparticles achieved lung-selective nucleic acid transfection in vivo.
- Specific formulations (Poly MDET-C4, Poly MDET-C6) mediated high protein expression in lung alveolar macrophages and dendritic cells.
- No significant tissue damage or systemic inflammatory responses were observed.
Conclusions:
- A simple, excipient-free, polyester-based nanoparticle platform enables lung-selective nucleic acid delivery.
- The platform effectively targets innate immune cells in the lungs, showing potential for genetic medicine.
- This approach simplifies production and may accelerate the clinical deployment of polymer-based genetic therapies.

